Health, Fitness & Food

In this article DOCS Follow your favorite stocksCREATE FREE ACCOUNT Doximity at the New York Stock Exchange for its initial public offering on June 24, 2021. Source: NYSE Shares of Doximity popped 25% in extended trading on Thursday after the company reported third-quarter fiscal 2025 results that beat analysts’ expectations for revenue and offered rosy
0 Comments
In this article GOOGL ELV Follow your favorite stocksCREATE FREE ACCOUNT Verily headquarters in San Bruno, California. Courtesy: Verily Verily is selling its stop-loss insurance subsidiary, Granular Insurance Company, to the insurance provider Elevance Health, the Alphabet health tech company confirmed to CNBC on Thursday. Verily is one of Google’s sister companies and operates within
0 Comments
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024.  Ore Huiying | Bloomberg | Getty Images Eli Lilly on Thursday said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide later this year, which is a
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT It’s been a rocky few months for Novo Nordisk. Prescription data from IQVIA suggests Novo’s obesity drug Wegovy is losing ground to rival Zepbound from Eli Lilly. Wegovy’s potential successor, CagriSema, came up short of investor expectations in a closely watched Phase 3 trial. Novo’s
0 Comments
Looking to reduce our exposure to tariffs and China, we’re making changes in the portfolio. We’re exiting our position in Stanley Black & Decker , selling our remaining 510 shares at roughly $86.79 each. We’re buying 50 shares of Home Depot at roughly $409.60. Following the trade, Jim Cramer’s Charitable Trust will own 300 shares
0 Comments
In this article NVO LLY NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Packages of weight loss drugs Wegovy, Ozempic and Mounjaro. Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy
0 Comments
In this article MRK Follow your favorite stocksCREATE FREE ACCOUNT Sopa Images | Lightrocket | Getty Images Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street’s expectations, as the company temporarily paused shipments of a key vaccine into China.  Shares of Merck fell more than 7% in premarket trading Tuesday.
0 Comments
Shana Novak | Stone | Getty Images President Donald Trump’s steep tariffs on Canada, Mexico and China could worsen ex­ist­ing drug shortages in the U.S., raise healthcare costs for patients and threaten cash-strapped generic drugmakers, some drug trade groups warn. Trump on Saturday announced he would impose a 25% tariff on nearly all goods shipped
0 Comments
Reid Hoffman, Partner at Greylock and co-founder LinkedIn, speaks during the WSJ Tech Live conference hosted by the Wall Street Journal at the Montage Laguna Beach in Laguna Beach, California, on October 21, 2024. Frederic J. Brown | Afp | Getty Images LinkedIn co-founder and venture capitalist Reid Hoffman became a billionaire from his business
0 Comments
Robert Kennedy Jr., U.S. President-elect Donald Trump’s nominee to run the Department of Health and Human Services, arrives at the Hart Senate Office Building on Capitol Hill in Washington, U.S., December 16, 2024.  Benoit Tessier | Reuters As Robert F. Kennedy Jr. faces two days of Senate confirmation hearings this week in his quest to
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters The Food and Drug Administration on Tuesday approved Novo Nordisk‘s Ozempic to treat chronic kidney disease in patients who also have Type
0 Comments
Robert F. Kennedy Jr., U.S. President Trump’s nominee to be secretary of Health and Human Services, testifies before a Senate Health, Education, Labor, and Pensions (HELP) Committee confirmation hearing on Capitol Hill in Washington, U.S., Jan. 30, 2025.  Nathan Howard | Reuters Robert F. Kennedy Jr., President Donald Trump‘s pick to lead the Department of
0 Comments
In this article VRTX Follow your favorite stocksCREATE FREE ACCOUNT A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters The Food and Drug Administration on Thursday approved Vertex Pharmaceuticals‘ non-opioid painkiller pill, a new alternative for pain relief that comes without the risk of addiction.  Vertex
0 Comments
Robert F. Kennedy Jr., President Donald Trump‘s controversial pick to lead the Department of Health and Human Services, testified Wednesday before a crucial Senate panel, where he faced questions about past vaccine skepticism, his evolving views on abortion and grasp on sprawling federal health programs. Kennedy, 71, appeared first before the Senate Committee on Finance,
0 Comments
Danaher shares are under pressure Wednesday as the Club holding’s fourth-quarter earnings results came in mixed and guidance disappointed. The company long known for its operational excellence is further testing our patience. Revenue for the three months ended Dec. 31 advanced 2% year over year on a reported basis, to $6.54 billion, outpacing the LSEG
0 Comments
In this article ME Follow your favorite stocksCREATE FREE ACCOUNT Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday, March 10, 2023.  Jordan Vonderhaar | Bloomberg | Getty Images Embattled genetic testing company 23andMe said on Tuesday that it’s started exploring
0 Comments
In this article UNH Follow your favorite stocksCREATE FREE ACCOUNT U.S. President Donald Trump attends a House Republican members conference meeting in Trump National Doral resort, in Miami, Florida, U.S. Jan. 27, 2025.  Elizabeth Frantz | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news
0 Comments
We are selling 75 shares of GE Healthcare at roughly $90 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 900 shares of GEHC, decreasing its weighting to about 2.25% from 2.42%. We’re taking advantage of the market’s rotation into health-care stocks by locking in profits in GE Healthcare. Following an up-and-down 2024, GE
0 Comments
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November 20, 2020. Carlos Barria | Reuters Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden took a hardline stance on
0 Comments